Paxlovid Not Helpful for Reducing Most Post-COVID-19 Conditions

TUESDAY, Oct. 31, 2023-- Outpatient treatment of COVID-19 with nirmatrelvir-ritonavir (Paxlovid) reduces the risk for combined thromboembolic events, but does not affect the risk for other post-COVID-19 conditions (PCCs), according to a study...